Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Apr;68(4):521–524. doi: 10.1136/adc.68.4.521

HIV infection in haemophilia--a European cohort.

A Aronstam 1, B Congard 1, D I Evans 1, C F Gazengel 1, U Herberg 1, F G Hill 1, P M Jones 1, R Ljung 1, E P Mauser-Bunschoten 1, E Scheibel 1, et al.
PMCID: PMC1029282  PMID: 8099271

Abstract

Ten haemophilia centres in northern Europe have pooled data on 202 haemophilic children who were infected with HIV between 1979 and 1986. All cases were under 16 years of age on 1 July 1985. The age at infection ranged from 1-15 years. Thirty seven cases (18%) had progressed to AIDS by 1 July 1991 and 15 of these have died. Persistent generalised lymphadenopathy has been noted in 102 patients of whom 18 (17%) have developed AIDS. Twenty three of the remaining patients (23%) have not. CD4+ T cell counts have fallen steadily. Of 36 patients who have had shingles since seroconversion, 19 (53%) had counts below 0.2 x 10(9)/l. Thirty five out of 145 patients without shingles (24%) had similar values. The mean IgA concentration in patients with CD4+ T cell counts above 0.5 x 10(9)/l was 2.38 g/l, between 0.2 and 0.5 was 3.07 g/l, and in those with CD4+ T cell counts below 0.2 x 10(9)/l the mean IgA concentration was 4.58 g/l. Treatment patterns have altered between 1989 and 1991, with increased use of zidovudine in patients without AIDS and a marked increase in primary prophylaxis against pneumocystis pneumonia. This has been associated with a decline in the incidence of pneumocystis as an indicator disease in new AIDS cases from 56% in 1989 to 20% in 1991. These observations indicate that persistent generalised lymphadenopathy does not worsen the outlook, but shingles does. Rising IgA concentrations are markers for disease progression. Modern prophylactic regimens are delaying the onset of indicator disease, but CD4 values continue to fall steadily.

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aledort L. M., Hilgartner M. W., Pike M. C., Gjerset G. F., Koerper M. A., Lian E. Y., Lusher J. M., Mosley J. W. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. BMJ. 1992 Jan 25;304(6821):212–216. doi: 10.1136/bmj.304.6821.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brettler D. B., Levine P. H. Factor concentrates for treatment of hemophilia: which one to choose? Blood. 1989 Jun;73(8):2067–2073. [PubMed] [Google Scholar]
  3. Cuthbert R. J., Ludlam C. A., Tucker J., Steel C. M., Beatson D., Rebus S., Peutherer J. F. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. BMJ. 1990 Oct 27;301(6758):956–961. doi: 10.1136/bmj.301.6758.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goedert J. J., Kessler C. M., Aledort L. M., Biggar R. J., Andes W. A., White G. C., 2nd, Drummond J. E., Vaidya K., Mann D. L., Eyster M. E. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989 Oct 26;321(17):1141–1148. doi: 10.1056/NEJM198910263211701. [DOI] [PubMed] [Google Scholar]
  5. Jason J. M., Stehr-Green J., Holman R. C., Evatt B. L. Human immunodeficiency virus infection in hemophilic children. Pediatrics. 1988 Oct;82(4):565–570. [PubMed] [Google Scholar]
  6. Lee C. A., Phillips A. N., Elford J., Janossy G., Griffiths P., Kernoff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ. 1991 Nov 2;303(6810):1093–1096. doi: 10.1136/bmj.303.6810.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lee C. A., Phillips A., Elford J., Miller E. J., Bofill M., Griffiths P. D., Kernoff P. B. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol. 1989 Oct;73(2):228–234. doi: 10.1111/j.1365-2141.1989.tb00257.x. [DOI] [PubMed] [Google Scholar]
  8. Sullivan J. L., Brewster F. E., Brettler D. B., Forsberg A. D., Cheeseman S. H., Byron K. S., Baker S. M., Willitts D. L., Lew R. A., Levine P. H. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr. 1986 Apr;108(4):504–510. doi: 10.1016/s0022-3476(86)80823-x. [DOI] [PubMed] [Google Scholar]
  9. Wagner N., Bialek R., Radinger H., Becker M., Schneweis K. E., Brackmann H. H., Niese D. HIV-1 infection in a cohort of haemophilic patients. Arch Dis Child. 1990 Dec;65(12):1301–1304. doi: 10.1136/adc.65.12.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wagner N., Bialek R., Radinger H., Brackmann H. H., Becker M. Intravenous immunoglobulin in HIV-I infected haemophilic patients. Arch Dis Child. 1992 Oct;67(10):1267–1271. doi: 10.1136/adc.67.10.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES